Alperin, Samuel http://orcid.org/0000-0003-4703-2870
Krueger, Darcy A.
Franz, David N.
Agricola, Karen D.
Stires, Gabrielle
Horn, Paul S.
Capal, Jamie K.
Funding for this research was provided by:
TSC Autism Center of Excellence Research Network
Article History
Received: 9 August 2021
Accepted: 23 November 2021
First Online: 13 December 2021
Declarations
:
: The CCHMC Institutional Review Board approved the protocol through which this research was performed. Informed consent was obtained from adult participants and from parents or guardians for participants under 18 years of age. Assent was provided by participants when able per institutional requirements.
: Not applicable
: Samuel Alperin, Karen D. Agricola, Gabrielle Stires, and Paul S. Horn have no disclosures. Darcy Krueger reports consulting fees and/or research support from Novartis Pharmaceuticals, TS Alliance, Druggability Technologies, Greenwich Biosciences, and Marinus Pharmaceuticals. Dr. Krueger also has received speaking fees from Novartis Pharmaceuticals and Greenwich Biosciences. David N. Franz reports travel support and honoraria from Novartis (more than 2 years ago). His employer has also received support for clinical trials and consulting work from Novartis (more than 2 years ago). Jamie K. Capal receives research support from Roche.